Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Cardiopulmonary Resuscitation III: AED Use

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...

Cardiac Catheterization IV: Nursing Management

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Myocardial Infarction Injury Is Exacerbated by Nicotine in Vape Aerosol Exposure.

Journal of the American Heart Association·2024

Same author

Individualized pretest risk estimates to guide treatment decisions in patients with clinical high risk for psychotic disorders.

Spanish journal of psychiatry and mental health·2024

Same author

Pathways to care in youth and young adults at clinical high risk for psychosis in Switzerland: Current situation and clinical implementation of the PsyYoung project.

Early intervention in psychiatry·2024

Same author

Cannabis Use: A New Risk Behaviour Among Adults With Congenital Heart Disease.

CJC pediatric and congenital heart disease·2024

Same author

Identifying Clinical Phenotypes in People Who Are Hispanic/Latino With Chronic Low Back Pain: Use of Sensor-Based Measures of Posture and Movement, Pain, and Psychological Factors.

Physical therapy·2024

Same author

Assessing Predictive Ability of Dynamic Time Warping Functional Connectivity for ASD Classification.

International journal of biomedical imaging·2023

Same journal

What is the significance of T-wave inversion in the precordial leads?

Progress in cardiovascular nursing·2009

Same journal

Sepsis and cardiac disease: improving outcomes through recognition and management.

Progress in cardiovascular nursing·2009

Same journal

Hypertension in Thailand.

Progress in cardiovascular nursing·2009

Same journal

Nutrigenomics in cardiovascular disease: implications for the future.

Progress in cardiovascular nursing·2009

Same journal

Lipoprotein-associated phospholipase A(2): a promising vascular-specific marker for screening cardiovascular risk?

Progress in cardiovascular nursing·2009

Same journal

Coronary artery bypass graft surgery patient education: a systematic review.

Progress in cardiovascular nursing·2009

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Cardiac support devices.

Marnie Rodger¹, Marion E McRae, Munira Jaffer

¹Cardiovascular Surgery Service, Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, ON M5G 2N2, Canada. marnie.rodger@uhn.on.ca

Progress in Cardiovascular Nursing

|December 17, 2009

Summary

This summary is machine-generated.

Heart failure, a common condition, involves progressive left ventricular enlargement. Surgical treatments, including cardiac support devices, offer new hope for improving survival and quality of life in patients.

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Experiment Videos

Last Updated: Jun 17, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Area of Science:

Cardiology and Cardiac Surgery
Medical Device Technology

Background:

Heart failure (HF) is a prevalent and serious condition in the US, marked by high mortality and significant healthcare costs.
HF is characterized by chronic, progressive left ventricular enlargement and dysfunction.
Current medical therapies can slow but not reverse left ventricular remodeling.

Observation:

Surgical interventions have emerged as crucial for enhancing survival and quality of life in HF patients.
Cardiac support devices represent a novel therapeutic avenue for advanced heart failure.
This review examines surgical procedures for left ventricular dysfunction, emphasizing cardiac support devices.

Findings:

Surgical approaches, particularly cardiac support devices, offer improved outcomes for heart failure patients.
The integration of cardiac support devices into treatment protocols is a key development in managing left ventricular dysfunction.
Nursing care protocols are essential for successful patient management with these devices.

Implications:

Cardiac support devices hold significant potential to transform heart failure management.
Further research and clinical application of these devices can reduce mortality and improve patient well-being.
Optimized nursing care is critical for the safe and effective use of cardiac support devices in heart failure patients.